Ngā hua rapu kaituhi :: APM

1

Is the COVID‐19 thrombotic catastrophe complement‐connected? mā Edward M. Conway, Edward L.G. Pryzdial

I whakaputaina 2020

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
2

Coagulation and complement: Key innate defense participants in a seamless web mā Edward L.G. Pryzdial, Alexander Leatherdale, Edward M. Conway

I whakaputaina 2022

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
3

Dengue virus binding and replication by platelets mā Ayo Yila Simon, Michael R. Sutherland, Edward L.G. Pryzdial

I whakaputaina 2015

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
4

Host cellular annexin II is associated with cytomegalovirus particles isolated from cultured human fibroblasts mā J. Fraser Wright, Alexander Kurosky, Edward L.G. Pryzdial, Safia Wasi

I whakaputaina 1995

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
5

Coagulation initiated on herpesviruses mā Michael R. Sutherland, Christina M. Raynor, Henriette Leenknegt, J. Fraser Wright, Edward L.G. Pryzdial

I whakaputaina 1997

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
6

Thrombin generates previously unidentified C5 products that support the terminal complement activation pathway mā Michael J. Krisinger, Verena Goebeler, Zhen Lu, Scott C. Meixner, Timothy Myles, Edward L.G. Pryzdial, Edward M. Conway

I whakaputaina 2012

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
7

Alteration of blood clotting and lung damage by protamine are avoided using the heparin and polyphosphate inhibitor UHRA mā Manu Thomas Kalathottukaren, Libin Abraham, Piyushkumar R. Kapopara, Benjamin Lai, Rajesh A. Shenoi, Federico I. Rosell, Edward M. Conway, Edward L.G. Pryzdial, James H. Morrissey, Charles A. Haynes, Jayachandran N. Kizhakkedathu

I whakaputaina 2016

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
8

Rivaroxaban and apixaban induce clotting factor Xa fibrinolytic activity mā R.L.R. Carter, Kimberley Talbot, Woosuk S. Hur, Scott C. Meixner, J. Grace van der Gugten, Daniel T. Holmes, Hélène C. F. Côté, Christian J. Kastrup, Tyler Smith, A.Y.Y. Lee, Edward L.G. Pryzdial

I whakaputaina 2018

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i: